Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 2896-2903, July 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Osanai, M.
Right arrow Articles by Lee, G.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osanai, M.
Right arrow Articles by Lee, G.-H.

Phenobarbital Causes Apoptosis in Conditionally Immortalized Mouse Hepatocytes Depending on Deregulated c-myc Expression: Characterization of an Unexpected Effect1

Makoto Osanai, Katsuhiro Ogawa and Gang-Hong Lee2

Department of Pathology, Asahikawa Medical College, 4-5-3-11 Nishikagura, Asahikawa 078, Japan

The CHST8 mouse hepatocyte cell line, conditionally immortalized with the temperature-sensitive SV40 large T antigen gene, rapidly proliferates at 33°C with active expression of the c-myc proto-oncogene but, due to the heat-labile nature of the mutant T antigens, becomes growth arrested and morphologically senescent at 39°C; this is accompanied by the disappearance of c-myc transcripts. In a previous study, we transfected the CHST8 cells at 33°C with an activated c-H-ras or a c-myc, both of which are frequently involved in mouse hepatocarcinogenesis in vivo. When the temperature was shifted to 39°C, cells with only one of the exogenous oncogenes did not escape from the senescence, but those containing both exhibited an immortal phenotype. In the present study, using this in vitro model of hepatocarcinogenesis, we demonstrated that phenobarbital, a tumor promoter of rodent hepatocarcinogenesis, triggers remarkable apoptosis specifically in the c-myc-transfected CHST8 cells at 39°C, which show abundant c-myc expression despite growth arrest. Dissociation of p53 proteins from degrading T antigens followed by a phenobarbital and c-myc-dependent, 15-fold induction of Bax protein, known to activate the apoptotic pathway downstream of p53, occurred in association with this phenomenon. The effects of phenobarbital and c-myc in increasing Bax on shifting the temperature from 33°C to 39°C were additive, with both having similar degrees of influence on the protein level. Interestingly, subsequent introduction of an activated c-H-ras oncogene into the c-myc-transfected CHST8 cells resulted not only in escape from the growth arrest at 39°C but also in complete inhibition of the phenobarbital-inducible apoptosis along with de novo induction of the Bax antagonist, Bcl-2. These findings strongly suggest that the phenobarbital-inducible apoptosis is mediated by Bax. Although it is a common notion that phenobarbital promotes liver tumor development through suppression of apoptosis, our results, together with the known fact that phenobarbital occasionally inhibits hepatocarcinogenesis in mice, indicate a problematic complexity in its biological activities.

1 This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture; the Ministry of Health and Welfare; and the Akiyama Memorial Foundation, Japan.

2 To whom requests for reprints should be addressed. Fax: 81-0166-65-8669.

Received 1/14/97. Accepted 5/14/97.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Osanai and M. Petkovich
Expression of the Retinoic Acid-Metabolizing Enzyme CYP26A1 Limits Programmed Cell Death
Mol. Pharmacol., May 1, 2005; 67(5): 1808 - 1817.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. Iida, H. Iwata, H. Inoue, M. Enomoto, N. Horie, and K. Takeishi
Correlation between Bcl-2 Overexpression and H-ras Mutation in Naturally Occurring Hepatocellular Proliferative Lesions of the B6C3F1 Mouse
Toxicol. Sci., August 1, 2000; 56(2): 297 - 302.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
G.-H. Lee
Review Article: Paradoxical Effects of Phenobarbital on Mouse Hepatocarcinogenesis
Toxicol Pathol, March 1, 2000; 28(2): 215 - 225.
[Abstract] [PDF]


Home page
Toxicol SciHome page
N. Finnberg, U. Stenius, and J. Hogberg
Xenobiotics Modulate the p53 Response to DNA Damage in Preneoplastic Enzyme-Altered Foci in Rat Liver; Effects of Diethylnitrosamine and Phenobarbital
Toxicol. Sci., March 1, 2000; 54(1): 95 - 103.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.